Overview of Diazinon

Property	Description
Active ingredient	Diazinon (Dimpylate)
Pharmacological class	Organophosphate Insecticide, Ectoparasiticide
Origin	Synthetic (Organophosphorus compound)
Common form	Emulsifiable concentrates, wettable powders, dusts, pour-on solutions
Common use	Control of external parasites (e.g., ticks, mites, fleas)

Defining the Compound and Its Origin

Diazinon, known by the international non-proprietary name (INN) Dimpylate, is a synthetic chemical substance classified as an organophosphorus compound. This active ingredient is a thiophosphoric acid ester and does not originate from natural sources. Diazinon's identity is chemically defined as O,O-diethyl O-[6-methyl-2-(1-methylethyl)-4-pyrimidinyl] phosphorothioate. The pure compound is a colorless oil, though it is formulated into various preparations for practical use as a single active ingredient product.

Pharmacological Class and General Purpose

Diazinon is formally classified as an Organophosphate Insecticide, Organophosphate Acaricide, and Ectoparasiticide. This designation confirms its primary function as a substance engineered for the elimination of external pests. Its general purpose is the rapid, non-systemic control of common parasites and insects, addressing infestations of creatures such as fleas, ticks, mites, and lice in relevant contexts. Diazinon is characterized by broad-spectrum insecticidal activity. As a key differentiator within its class, Diazinon has been historically prominent in applications such as treating sheep for lice and tick infestations or controlling household insect populations before use restrictions were updated.

Common Forms and Preparations

Diazinon is supplied in various physical forms to facilitate its use via topical application or environmental dispersal, reflecting its non-systemic nature. The typical dosage forms include emulsifiable concentrates and wettable powders, which are prepared with water to form solutions for washes, as well as forms like dusts and granules. The availability of these distinct preparations allows for flexibility in application, such as preparing aqueous solutions for external animal treatment or utilizing granules for agricultural soil pest control.

What side effects are possible with Diazinon?

Possible Side Effects and Safety Information: Diazinon (Dimpylate)

The safety profile of Diazinon, an organophosphate compound, is defined by its inherent toxicity as documented in government toxicological and public health reports. These documents focus on the consequences of exposure rather than traditional clinical trial frequency classifications. Adverse effects are universally linked to the primary toxic effect: the inhibition of acetylcholinesterase.

Documented Adverse Reactions and Organ Systems

The severity of adverse reactions is directly correlated with the level and duration of exposure. Effects are categorized by the body systems affected by cholinergic overstimulation:

Nervous System Disorders: Headache, dizziness, weakness, anxiety, tremors, and, in severe cases, convulsions, coma, and flaccid paralysis.
Gastrointestinal Disorders: Nausea, vomiting, abdominal cramps, and diarrhea.
Ocular and Respiratory Disorders: Constriction of the pupils (miosis), blurred vision, and life-threatening conditions such as pulmonary edema and respiratory arrest.

Serious Adverse Reactions and Safety Patterns

The most serious outcomes documented in regulatory sources include coma, seizures, and respiratory failure resulting from acute, high-level exposure. A delayed, serious effect known as Intermediate Syndrome—characterized by muscle weakness and paralysis—may also occur following recovery from the initial toxicity.

Time-related patterns indicate symptoms may begin within minutes to an hour of high exposure but can also be delayed by up to 24 hours and may persist for several days or weeks. Furthermore, regulatory bodies note that the pediatric population may exhibit increased susceptibility to the compound's adverse neurological effects. The US Environmental Protection Agency (EPA) classifies Diazinon as a "not likely human carcinogen."

Overdose and Emergency Response

Overdose and When to Seek Help

Exposure to Diazinon, an organophosphate compound, necessitates immediate medical attention due to the potential for acute, severe systemic poisoning. Any suspected or known exposure is officially classified as a medical emergency. Government guidance mandates that individuals must immediately contact emergency medical services or a national poison control center for urgent treatment instructions.

Documented Clinical Manifestations

Acute overdose is characterized by signs of cholinergic overactivity, which can include constricted (pinpoint) pupils, profuse sweating, excessive salivation, headache, and severe gastrointestinal distress (nausea, vomiting, diarrhea). Neurological manifestations such as muscle twitching (fasciculations), loss of coordination, confusion, and seizures are also documented outcomes.

Life-Threatening Risks and Interventions

Severe exposure carries the risk of life-threatening complications, including respiratory arrest, pulmonary edema, coma, and cardiac failure. Due to these risks, hospital monitoring is required. Emergency medical management includes symptomatic and supportive care, thorough physical decontamination (washing skin, removal of clothing), and the procedural administration of a specific antidote to reverse the systemic effects. Patients may require advanced breathing support.

Therapeutic Uses of Diazinon

Quick Facts

Approved Use Category: Used for the control of pest insects in specific non-residential settings, primarily agricultural.
Therapeutic Domain: Functions to mitigate the presence of certain insects on field crops, fruits, vegetables, and nuts.
Livestock Application: May be used in impregnated materials, such as ear tags, on non-lactating cattle to address external pests.

What Diazinon Addresses: Main Uses

Diazinon is an organophosphate compound employed as an insecticide to help manage the presence of pest insects. It is primarily utilized in the agricultural sector and for specific applications related to livestock. The use of this substance is regulated, and its residential use has been restricted in many jurisdictions due to health considerations.

Its function relates to mitigating the presence of various pests, including mites, ticks, and nematodes (roundworms) in specific settings.

Current Approved Contexts

In agricultural settings, diazinon is applied to help manage pest populations on certain food crops, including fruits, nuts, vegetables, and field crops. In some jurisdictions, current registered uses are limited to agriculture and livestock applications, such as for the development of insecticidal ear tags for cattle. The widespread use of the compound in non-agricultural contexts, like home and garden products, has been subject to cancellation and phase-out measures due to safety concerns.

Eligibility and Restrictions for Use

The eligibility profile for Diazinon (Dimpylate) is defined by its regulatory classification as a Restricted Use Pesticide, not a human pharmaceutical. Therefore, eligibility is structured around certified use and mandatory exposure restrictions.

Eligibility scope

Field	Official Regulatory Statement
Populations for whom use is allowed	Certified Applicators/Operators only, for approved agricultural and livestock uses under strict occupational standards [Source 3.2, 3.3].
Populations for whom use is contraindicated	The General Public/Residential Users are absolutely contraindicated, as all indoor, lawn, garden, and general residential uses were formally canceled [Source 1.5, 3.6].
Age-related eligibility rules	Children/Infants must be restricted from entering treated areas until sprays have dried due to high susceptibility; use is restricted to Adults who meet Certified Applicator status [Source 2.1, 3.2].
Condition-specific eligibility rules	Not documented. No patient-specific comorbidity rules (e.g., hepatic or renal impairment) are recorded, as the product is an insecticide, not a therapeutic medicine [Source 2.2].
Pregnancy and lactation eligibility status	Pregnant Individuals must avoid exposure due to documented association between prenatal exposure and adverse developmental outcomes [Source 2.4, 2.7].

Resulting eligibility structure

Official eligibility statements:

General Public use is absolutely contraindicated due to regulatory cancellation of all residential applications.
Eligibility for product use is restricted only to Certified Applicators for approved agricultural contexts.
Exposure to children/infants and pregnant individuals is severely restricted due to high susceptibility and documented developmental hazards.

Connection to the overall eligibility profile: The official eligibility profile is defined by use authorization and exposure prohibition. Regulatory documents establish an absolute prohibition on general public use and limit eligibility for application solely to trained, certified personnel operating in approved non-residential settings.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Diazinon (Dimpylate) is an organophosphate insecticide whose official interaction profile is detailed in government toxicological and public health regulatory documents, focusing on its core action as a cholinesterase inhibitor.

Interaction Scope

Property	Official Regulatory Information
Medicinal product categories with documented interactions	Organophosphate (OP) Compounds and Carbamate Insecticides
Mechanistic basis of interactions	Additive Cholinesterase Inhibition; Potentiation of Neurologic Toxicity (with Triazines)
Food, Alcohol, Herbal Product Interactions	Alcohol

Official Interaction Statements

Co-exposure to other Organophosphate compounds and Carbamate Insecticides is documented to result in additive neurotoxicity due to compounded cholinesterase inhibition. Regulatory documents mandate the avoidance of such co-exposure because the interaction poses a significant toxicological hazard.

Alcohol consumption is explicitly documented to increase the risk of liver damage (hepatotoxicity) associated with Diazinon exposure.

Furthermore, the Agency for Toxic Substances and Disease Registry (ATSDR) notes that Triazine components (e.g., Atrazine) may potentiate the neurologic toxicity of Diazinon in mixture scenarios.

Interaction risk is subject to population differences, with regulatory assessments noting that younger organisms were more sensitive to the nervous system effects. This overall profile is defined by pharmacodynamic reinforcement, establishing mandatory constraints against co-exposure to other cholinesterase-inhibiting substances.

Mechanism of Action

Mechanism of Action: Cholinesterase Inhibition

Diazinon acts not as the active agent, but is first metabolically converted into Diazoxon via oxidative desulfuration within the target organism. Diazoxon functions as an irreversible inhibitor of the enzyme Acetylcholinesterase ( AChE). This process involves the phosphorylation of the serine residue in the AChE active site, forming a stable covalent bond that disables the enzyme.

The inactivation of AChE prevents the hydrolysis of the neurotransmitter acetylcholine ( ACh), resulting in its significant accumulation in the synaptic clefts of the central and peripheral nervous systems. This overload causes the persistent overstimulation of the entire cholinergic system, leading to sustained depolarization and the functional failure of nerve and muscle cells. This persistent nerve signaling subsequently results in uncontrolled muscle firing (fasciculations) that progresses to tetanic paralysis and systemic physiological failure in the target organism. The differential action of the compound relates to the target organism’s lower capacity to detoxify the active metabolite.

Dosage and Administration Information

Administration Scope

The usage of Diazinon is strictly regulated as an organophosphate ectoparasiticide and insecticide, with instructions governing environmental and non-human applications, as it is not approved for human medicinal use. Application methods and rates are highly dependent on the target area or organism.

Instruction Entity	Official Labeled Guideline
Route of administration	Environmental Dispersal (foliar spray, soil incorporation, chemigation); Topical (e.g., via impregnated ear tags for livestock).
Dosing schedule	Defined by Application Rate, typically measured in pounds of active ingredient (a.i.) per acre, or by a required Dilution Concentration for liquid formulations.
Timing in relation to use	Application is typically directed at the first sign of pests and must observe a minimum re-treatment interval as specified by the label.
Preparation requirements	Concentrated formulations (Emulsifiable Concentrates or Wettable Powders) require dilution with water and subsequent vigorous agitation to ensure a uniform spray suspension.
Population-specific rules	Use of impregnated materials (ear tags) is typically restricted to non-lactating cattle. Application rates are highly crop-specific (e.g., stone fruits vs. berries).

Instruction Classifications

Classification Entity	Official Label Pattern
Frequency pattern	Intermittent/As-Needed (based on pest presence); subject to a maximum number of applications per season.
Use-context constraints	Mandatory observance of the Pre-Harvest Interval (PHI), a specified waiting period (e.g., 7 to 28 days) between final application and crop harvest.

Resulting Procedural Structure

Official step sequence (High-level procedural steps derived from regulatory labels):

Determine the precise, label-mandated Application Rate for the target crop and pest.
Dilute the concentrated product with water, maintaining continuous agitation during application.
Apply the product via the approved route, ensuring no spray overlap and adhering to all application conditions.
Observe the specified Pre-Harvest Interval (PHI) before crop harvest.

Connection to the overall use protocol (2–4 sentences): The official protocol for Diazinon establishes strict parameters for its external use, requiring meticulous adherence to specified dilution ratios and application techniques to ensure consistency with labeled rates. The guidelines govern the timing of application relative to both pest activity and the crop cycle, enforcing limits such as the maximum amount of active ingredient permitted annually and the final waiting period before harvest.

Recent Clinical Evidence

Diazinon: Recent Clinical Evidence

Diazinon is an organophosphate insecticide whose primary toxic effect in humans and animals is the inhibition of the enzyme acetylcholinesterase (AChE). This mechanism leads to the accumulation of acetylcholine at nerve receptors, resulting in cholinergic responses, primarily affecting the nervous system.

Studies on Human Exposure and Symptoms

Clinical evidence regarding diazinon exposure largely comes from case reports of accidental or intentional poisoning, as well as epidemiological studies on occupational exposure. Symptoms of high-level acute exposure typically manifest within minutes to 24 hours and range from mild effects like headache, dizziness, and blurred vision to severe effects such as nausea, vomiting, muscle twitching, difficulty breathing, convulsions, coma, and potentially death due to respiratory or cardiac failure.

Long-Term Neurological and Cancer Findings

Long-term exposure studies have primarily focused on occupational cohorts, particularly pesticide applicators. An updated evaluation within the Agricultural Health Study (AHS) cohort provided additional evidence of an association with an elevated risk of lung cancer among those with the greatest lifetime exposure days. Associations with kidney cancer and aggressive prostate cancer have also been newly identified, though they require further evaluation.

Regulatory and Safety Profile

Diazinon is no longer approved for residential use in many regions, including the United States, following a phase-out due to human health risks, particularly concerning children's exposure. The International Agency for Research on Cancer (IARC) has classified diazinon as Group 2A: probably carcinogenic to humans, based on limited evidence in humans and convincing mechanistic evidence. Monitoring of exposure is typically performed by measuring the inhibition levels of cholinesterase enzymes in the blood (plasma and red blood cell AChE activity).

Key Studies & References

Frequently Asked Questions (FAQ)

Research Evidence / Overview of Studies for Diazinon

Evidence for Use as an Insecticide (Agricultural/Livestock)

Research examined the application of Diazinon in restricted settings, such as in agriculture and livestock management. The available evidence primarily comes from field evaluations and non-human studies that monitored how pest populations evolved following application. These evaluations research described the immediate or short-term impact on various insect species and the residue levels found on treated surfaces or in food products. The findings describe patterns observed in these specific non-human studies research describes observed patterns.

However, the results apply only to the populations studied (pests and the environment in which they are applied) and data are still emerging regarding its environmental fate and persistence. These non-human field and laboratory studies provide context but research does not determine health outcomes related to human exposure. The follow-up durations were limited in many of the environmental studies, meaning long-term effects are not fully established regarding ecological impact.

Evidence on Acute Exposure and Poisoning Management

Research related to acute human exposure to Diazinon was evaluated in observational settings, primarily consisting of case reports and series that described the symptoms observed in cases involving accidental or intentional poisoning. These studies examined outcomes related to systemic or functional imbalance immediately following the event. The evidence in this area research describes the symptom patterns and health changes of individuals who experienced acute, high-level exposure, monitoring outcomes linked to inflammatory or irritative states and changes in physiological markers, such as acetylcholinesterase activity.

The findings help contextualize how patients reported their experience of severe symptoms, including the outcomes reflecting daily functioning or activity level during the acute event. This research provides insight into short-term changes that occur following a single, high-dose exposure. However, because these are not controlled clinical trials, the evidence quality varies across studies, and the data is limited to individuals who sought medical help for a poisoning event. The sample sizes were modest, and comparative evidence is lacking for different management strategies.

Evidence in Special Populations (Occupational/Residential Exposure)

Studies were observed in specific populations, such as agricultural workers who have repeated, low-level contact with the substance as part of their job. Other research explored outcomes related to physical discomfort and possible chronic health patterns in people living in close proximity to areas where the insecticide was used in observational settings evaluating daily-life functioning. Evidence also includes animal studies applied in research contexts involving fluctuating or unstable symptoms to research explored developmental or reproductive outcomes.

Data show patterns related to certain physiological markers being altered following chronic low-level exposure in some occupational cohorts. However, the findings were mixed when trying to link low-level exposure to specific long-term disease states, and the certainty remains low due to confounding factors in real-world settings. Data for certain groups remain insufficient, especially regarding pregnant individuals, developing fetuses, or very young children who may have unique vulnerabilities. The results apply only to the populations studied under the specific exposure conditions described.

Long-term Studies and Follow-up

Research was monitored to understand the long-term patterns associated with both acute and chronic exposure. These studies research explored short-term symptom changes but often extended the follow-up to check for delayed or persistent outcomes reflecting daily functioning or activity level. The evidence describes what was observed regarding the potential for persistent outcomes following an acute poisoning event.

There is limited information for long-term outcomes following chronic, low-level exposure. Most available human data follow-up durations were limited, typically lasting only a few years, making it difficult to fully characterize the persistence or reversibility of any measured changes. Therefore, long-term effects are not fully established, and research is ongoing to better understand the durability of observed physiological or functional changes.

What is Still Uncertain About Diazinon

The overall research landscape contributes to the broader evidence landscape, yet significant gaps or limitations exist in the research. Evidence is limited in defining clear cause-and-effect relationships between low-level, long-term environmental exposure and specific chronic diseases. The comparative evidence is lacking to fully assess the potential effects of Diazinon.

Furthermore, findings describe group patterns, not personal outcomes, and the individual factors that may influence sensitivity or recovery are not well understood. Subgroup findings are uncertain, as there is inadequate data to clearly separate the effects in specific age groups or in people with underlying health conditions. The research highlights what is known — and what is still uncertain—about this substance, indicating that more controlled and extended studies are needed to provide a clearer picture.

How should Diazinon be stored and disposed of?

Storage and Disposal of Diazinon

Storage and disposal of Diazinon, a regulated pesticide, must strictly adhere to official label instructions to prevent contamination and ensure security.

Storage Requirements

Constraint	Official Requirement
Environment	Store in a cool, dry, well-ventilated place, protected from freezing and direct sunlight [2.1, 2.2, 2.3].
Security	Must be stored locked up and out of the reach of children and pets [2.3].
Separation	Store separately from food, feedstuffs, strong acids, strong oxidants, and bases [2.1, 2.3].
Container	Keep in the original container and ensure it is tightly closed [2.2, 2.3].

Disposal Requirements

Official disposal rules classify Diazinon waste as toxic and prohibit disposal into sinks, toilets, or any body of water [2.2, 2.4]. Excess or unusable product must be handled by contacting the State Environmental Control Agency or EPA Regional Office for specific guidance [2.2]. Empty containers must not be reused and require specific cleaning (e.g., triple rinsing liquids) before disposal according to local regulations [2.1, 2.2].

Diazinon